For expectant parents, navigating prenatal dietary advice often feels like navigating conflicting medical doctrines. For years, maternal nutrition recommendations swung between extremes. In the early 2000s, clinical bodies commonly cautioned pregnant women to avoid allergenic foods like peanuts if their families had a history of allergies. When that strategy failed to curb rising allergy rates, the pendulum swung the opposite way: viral wellness advice began urging mothers to eat large quantities of allergenic foods during pregnancy to build in utero tolerance.
Now, a landmark phase 3 multi-center randomized controlled trial published in The New England Journal of Medicine (NEJM) on September 17, 2026, brings rigorous clinical evidence to this question. Known as the PrEggNut trial, the study evaluated whether pregnant women who consume high amounts of eggs and peanuts during pregnancy and lactation protect their infants from developing egg and peanut allergies. The findings offer definitive answers and welcome reassurance for expectant mothers.
The PrEggNut Trial: Study Design and Protocol
Researchers led by Dr. Debra J. Palmer conducted a multisite randomized trial across Australia to assess early immune tolerance. The team enrolled 2,137 pregnant women whose infants were at high hereditary risk (at least two first-degree biological relatives with diagnosed atopy).
Before 23 weeks of gestation, participants were randomly assigned in a 1:1 ratio to one of two dietary protocols followed through pregnancy and the first four months of lactation:
- High Egg-Peanut Group (1,070 participants): Mothers consumed at least 6 whole eggs and 60 peanuts (or equivalent peanut butter) each week.
- Standard Control Group (1,067 participants): Mothers maintained standard habits with limited intake, consuming no more than 3 eggs and 30 peanuts weekly.
Infants were clinically assessed at 12 months of age by pediatric allergists. The primary outcome was IgE-mediated egg or peanut allergy confirmed by skin-prick testing and oral food challenges.
What the Clinical Data Found
The trial found no statistically significant difference in infant food allergies between the two maternal dietary groups at one year of age.
Among infants evaluated at 12 months, 7.8% in the high egg-peanut group (83 of 1,066) developed an IgE-mediated allergy to egg or peanut, compared with 8.4% in the standard-diet group (89 of 1,064). This corresponded to a relative risk of 0.93 (95% confidence interval, 0.69 to 1.26; P = 0.65). Because this difference was not statistically significant, researchers concluded that maternal allergen loading does not confer protective clinical tolerance.
Secondary analyses showed similar results when evaluating peanut allergy and egg allergy separately. Furthermore, adverse pregnancy outcomes and eczema rates were comparable across groups. The trial affirmed that eating eggs and peanuts while pregnant and nursing is safe for non-allergic mothers, but does not act as an active prevention tool.
Comparing Prevention Strategies: Maternal Intake vs. Infant Feeding
The PrEggNut trial underscores that maternal digestion does not replace direct infant oral exposure, as compared below.
| Strategy | Timing Window | Proposed Mechanism | Clinical Outcome | Guideline Status |
|---|---|---|---|---|
| Maternal Allergen Loading (PrEggNut Trial, 2026) | <23 weeks gestation to 4 months postpartum | Placental antigen transfer and breast milk immunoglobulins | No significant allergy reduction (RR 0.93, P=0.65) | Not recommended as a prevention method; normal varied eating advised |
| Maternal Allergen Avoidance (Historical Advice) | Pregnancy and lactation | Antigen exclusion to prevent sensitization | No benefit; coincided with rising allergy rates | Rescinded by AAP and NIAID; unnecessary dietary restriction |
| Direct Infant Introduction (LEAP Trial, 2015) | Direct feeding from 4 to 11 months of age | Oral tolerance induction in infant gut-associated lymphoid tissue | 81% reduction in peanut allergy among high-risk infants | Standard active clinical guideline (AAP, NIAID, WHO consensus) |
| Early Cooked Egg Introduction (EAT / BEAT Trials) | Direct feeding from 4 to 6 months of age | Direct mucosal exposure to egg proteins | Significant reduction in IgE-mediated egg allergy | Recommended early complementary feeding practice |
Why In Utero Exposure Differs From Direct Oral Ingestion
Why did maternal loading fail while direct infant feeding in the LEAP trial succeeded? The answer lies in oral tolerance immunology.
Under the “dual-allergen exposure hypothesis,” infants develop food allergies primarily when allergen proteins enter through a disrupted skin barrier, such as in eczema. Cutaneous immune cells encounter intact proteins, driving IgE sensitization. In contrast, when intact allergenic proteins enter through the infant’s digestive tract, the gut-associated lymphoid tissue (GALT) generates regulatory T cells that teach the immune system to recognize the protein as benign.
During pregnancy and lactation, digested peptides and maternal antibodies cross into fetal circulation and breast milk. However, passive exposure does not program the infant immune system toward tolerance; direct mucosal exposure in the infant gut remains essential.
Actionable Guidance for Expectant Mothers and Families
The PrEggNut findings liberate expectant mothers from unproven dietary rules. Based on current consensus from the American Academy of Pediatrics (AAP) and the National Institute of Allergy and Infectious Diseases (NIAID), families should consider the following:
1. Eat Naturally Without Anxiety
Pregnant women do not need to force-feed themselves eggs or peanut butter, nor should they avoid them out of fear. Non-allergic mothers can enjoy both foods as part of a balanced diet. Whole eggs supply choline and lutein for fetal brain development, while peanuts offer protein, magnesium, and healthy fats.
2. Focus on the True Window: 4 to 6 Months
The established window for allergy prevention begins when the infant starts solid foods. NIAID and AAP guidelines recommend introducing age-appropriate peanut and cooked egg products around 4 to 6 months of age, once the infant demonstrates developmental readiness for solids.
3. Safe Preparation for Infants
Whole peanuts and spoonfuls of peanut butter are choking hazards and should never be given to infants. Instead, mix a teaspoon of smooth peanut butter into warm breast milk, formula, or pureed vegetables, or use soluble peanut puffs. Eggs should always be cooked thoroughly.
4. Consult a Pediatrician for High-Risk Babies
For infants with severe eczema or an existing egg allergy, consult a pediatrician or pediatric allergist before introducing peanuts. A medical professional can guide safe, supervised introductory feeding.
Study Limitations
The PrEggNut trial relied on self-reported dietary logs, and outcomes were assessed at 12 months. Ongoing follow-up will monitor respiratory outcomes in later childhood. Nonetheless, the core conclusion is clear: maternal allergen loading does not prevent infant food allergies, leaving direct infant feeding as the proven prevention strategy.
Explore more on HealAtlas: Healthy Foods for Kids by cuisine · healthy American foods for kids, with early peanut and egg tips · Middle Eastern foods for kids, including first tastes of sesame · Thai foods for kids, with safe peanut sauce tips
Sources and Further Reading
- Trial of a Maternal Diet Rich in Eggs and Peanuts to Reduce Infant Allergy — Palmer DJ, Campbell DE, Nanan R, et al. The New England Journal of Medicine, September 17, 2026. DOI: 10.1056/NEJMoa2605659.
- Addendum Guidelines for the Prevention of Peanut Allergy in the United States — National Institute of Allergy and Infectious Diseases (NIAID) Expert Panel Guidelines.
- Randomized Trial of Peanut Consumption in Infants at Risk for Peanut Allergy (LEAP Trial) — Du Toit G, Roberts G, Sayre PH, et al. The New England Journal of Medicine, 2015. DOI: 10.1056/NEJMoa1414850.
- The Effects of Early Nutritional Interventions on the Development of Atopic Disease in Infants and Children — Greer FR, Sicherer SH, Burks AW. Pediatrics, American Academy of Pediatrics Clinical Report, 2019.
- PubMed Record: PrEggNut Clinical Trial Data and Abstract (PMID 42748429) — National Library of Medicine.
Related Reading
- Food Allergy Blood Tests vs Oral Challenge: What Science Shows
- Vitamin D in Pregnancy May Boost Child Brain Health
- Diet and Autoimmune Disease: What NIH Research Reveals
Disclosure: This content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before making changes to your health regimen.